While the active ingredient, semaglutide, is the same molecule, the delivery method for compounded versions often involves a traditional vial and syringe
That makes cagrilintide less of a direct competitor and more of a potential alternative for people whose bodies dont respond well to GLP-1 therapy, or who struggle with its side effects
Ozempic comes in pre-loaded syringes with a dial to change dosages
Crucial Quote These phase two data have given us confidence to further explore the potential of retatrutide in phase three trials that will look beyond weight reduction and focus on treating obesity and its complications comprehensively, Dan Skovronsky, ELI Lilly's chief medical and scientific officer, said in a statement
Endocrinology 150 , 13411352 (2009)
Our experts Sarah Akram, celebrity aesthetician Dr